A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
Clinical trial NCT03196219 · COMPLETED
Trial details
- NCT number
- NCT03196219
- Sponsor
- Armata Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2017-11-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.